Cintas (CTAS)
(Delayed Data from NSDQ)
$205.62 USD
-0.19 (-0.09%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $205.53 -0.09 (-0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$205.62 USD
-0.19 (-0.09%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $205.53 -0.09 (-0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Zacks News
Ball Corp to Gain From High Beverage Can Demand, FX Woes Stay
by Zacks Equity Research
Continued strong demand for aluminum packaging and robust aerospace backlog are likely to aid Ball Corporation (BLL) achieve 2019 EBITDA target of $2 billion.
AptarGroup (ATR) Earnings Trump Estimates in Q2, Up Y/Y
by Zacks Equity Research
AptarGroup (ATR) puts up a stellar top-line performance in Q2, aided by solid broad-based demand for drug delivery and food dispensing solutions.
Owens-Illinois (OI) Q2 Earnings Lag Estimates, View Cut
by Zacks Equity Research
Higher operating costs led to Owens-Illinois (OI) Q2 results falling short of the Zacks Consensus Estimate as well as the year-ago results and is expected to hurt Q3 results as well.
TriMas (TRS) Q2 Earnings Meet Estimates, 2019 Outlook Raised
by Zacks Equity Research
TriMas (TRS) delivered year-over-year improvement in second-quarter earnings on improved performance across all segments despite higher input costs
The Zacks Analyst Blog Highlights: Walmart, Kimberly-Clark, McCormick & Company, PepsiCo and Cintas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, Kimberly-Clark, McCormick & Company, PepsiCo and Cintas
5 Top-Performing Dividend Aristocrats to Buy in August
by Tirthankar Chakraborty
From Fed's Powell dashing hopes of more rate cuts to no trade deal in sight, things aren't looking up for the stock market this August. In such a scenario, dividend stocks might help.
Top Stock Picks for the Week of July 22, 2019
by Tracey Ryniec
Tracey Ryniec takes a look at two highly ranked stocks that recently crushed it on earnings.
The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific
Here's Why Momentum Investors Will Love Cintas (CTAS)
by Zacks Equity Research
Does Cintas (CTAS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Cintas (CTAS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Cintas (CTAS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cintas (CTAS) Looks Good: Stock Adds 8.7% in Session
by Zacks Equity Research
Cintas (CTAS) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Top Stock Reports for Johnson & Johnson, NextEra & Deere
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), NextEra (NEE) and Deere (DE).
Cintas (CTAS) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Cintas' (CTAS) fourth-quarter fiscal 2019 revenues increase year over year on the back of solid organic revenue growth in both its segments.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
Cintas (CTAS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 6.70% and 0.66%, respectively, for the quarter ended May 2019. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks with Spectacular Earnings Charts
by Tracey Ryniec
These companies aren't just beating on earnings, their stocks are also on fire, hitting new 5-year highs.
Top Research Reports for Berkshire Hathaway, Pfizer & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Pfizer (PFE) and Danaher (DHR).
Cintas (CTAS) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Strength in the Uniform Rental and Facility Services segment and a solid product portfolio are likely to drive Cintas' (CTAS) fiscal Q4 results. However, high cost of sales poses a concern.
Here's Why it is Worth Holding on to Cintas (CTAS) Stock Now
by Zacks Equity Research
Cintas (CTAS) is well placed to reap benefits of its enterprise resource planning system, buyouts and solid product portfolio. However, high integration costs and huge debts are concerning.
The Zacks Analyst Blog Highlights: Kimberly-Clark, McCormick, PepsiCo and Cintas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kimberly-Clark, McCormick, PepsiCo and Cintas
Trade War Escalates: Buy These 4 Dividend Aristocrats Now
by Tirthankar Chakraborty
Trump threatens to raise tariffs on $200 billion of Chinese goods and adds fuel to trade tensions. Thus, in order to safeguard your portfolio, investing in dividend aristocrats seems prudent.
Cintas (CTAS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Cintas (CTAS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Berry Global (BERY) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Berry Global's (BERY) second-quarter fiscal 2019 revenues decline year over year due to weaker operational performance in Health, Hygiene & Specialties, and Engineered Materials segments.
Macquarie's (MIC) Q1 Earnings Decline Y/Y, Revenues Rise
by Zacks Equity Research
Macquarie's (MIC) first-quarter 2019 revenues rise year over year owing to strong operational performance of its in IMTT and Atlantic Aviation segments.
Parker-Hannifin (PH) Q3 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Parker-Hannifin's (PH) third-quarter fiscal 2019 revenues fall year over year due to softness in North American segment.